Pharmabiz1h
5th Student Research Congress hosted at SVKM’s BNCP towards pioneering innovations
Student Research Congress hosted at SVKM’s BNCP towards pioneering innovations: Shardul Nautiyal, Mumbai Thursday, December ...
Pharmabiz1h
Zeno Health launches 182nd medical store at Panvel
Zeno Health, India's leading omnichannel platform for quality and affordable generic medicines, recently launched its 182nd ...
Pharmabiz1h
China NMPA approves Keymed Biosciences’ sNDA for Stapokibart to treat chronic rhinosinusitis with nasal polyposis
China NMPA approves Keymed Biosciences’ sNDA for Stapokibart to treat chronic rhinosinusitis with nasal polyposis: Chengdu, China Thursday, December 26, 2024, 18:00 Hrs [IST] Ke ...
Pharmabiz2h
OBI Pharma inks agreements with GlyTech to expand GlycOBI enabling technologies in Japan to advance Glycan production
OBI Pharma, Inc, a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADC) and active immunotherapies, and GlyTech Inc, a ...
Pharmabiz2h
Mankind Pharma to market Innovent Biologics’ innovative PD-1 inhibitor, sintilimab to treat cancer in India
Our Bureau, Mumbai Thursday, December 26, 2024, 16:40 Hrs [IST] ...
Pharmabiz4h
Quantum-Si submits new paper to bioRxiv; demonstrates advances in protein variant detection using ProteoVue with next-generation protein sequencing
Quantum-Si submits new paper to bioRxiv; demonstrates advances in protein variant detection using ProteoVue with next-generation protein sequencing: Branford, Conn. Thursday, Dece ...
Pharmabiz5h
Rhythm receives US FDA nod for IMCIVREE to reduce excess body weight & maintain weight reduction long-term in children 2 years old
Rhythm receives US FDA nod for IMCIVREE to reduce excess body weight & maintain weight reduction long-term in children 2 years old: Boston, MA Thursday, December 26, 2024, 14:00 H ...
Pharmabiz6h
New clinical practice guideline on process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
An expert workgroup representing primary and specialty care has developed new guidelines for comprehensive evaluation of patients who may have cognitive impairment or dementia due to Alzheimer’s ...
Pharmabiz7h
Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics
Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics: Allschwil, Switzerland Thursday, December 26, 202 ...
Pharmabiz10h
Anavex Life Sciences receives EMA filing acceptance for blarcamesine to review marketing authorization application to treat Alzheimer’s disease
Anavex Life Sciences receives EMA filing acceptance for blarcamesine to review marketing authorization application to treat Alzheimer’s disease: New York Thursday, December 26, ...
Pharmabiz8h
US FDA approves the first acellular tissue engineered vessel ‘Symvess’ to treat vascular trauma in extremities
Silver Spring, Md Thursday, December 26, 2024, 11:00 Hrs [IST] ...
Pharmabiz3h
Sanofi begins phase 3 program for pneumococcal conjugate vaccine (PCV21); expands agreement with SK bioscience
Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both ...